The treatment of GISTs has achieved a breakthrough with imatinib mesylate, a molecularly targeted drug that can block the tyrosine kinase activation pathway and restrict tumor cell growth and apoptosis.
The treatment of GISTs has made a breakthrough with the help of methadone, a molecularly targeted drug that blocks the tyrosine kinase active path, restricting tumor cell growth and apoptosis.
Imatinib mesylate, a molecular targeted drug, has made a breakthrough in the treatment of GISTs. It can block the activation pathway of tyrosine kinase and restrict the growth and apoptosis of tumor cells.<br>